ArticleImmunoHorizons2024

Characterization of Turbo, a TLR Ligand-based Adjuvant for Glycoconjugate Vaccines.

Kishore R AlugupalliPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.